Crystal structure of outer membrane protein NMB0315 from Neisseria meningitidis

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wang, Xiangyu ^a   Yang, Xue ^a   Yang, Chunting ^b   Wu, Zhenhua ^b   Xu, Honglin ^b   Shen, Yuequan ^a  

^a NANKAI UNIVERSITY   (China)

^b NATIONAL VACCINE AND SERUM INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOSTAPHIN; METALLOPROTEINASE; OUTER MEMBRANE PROTEIN; PROTEIN NMB0315; UNCLASSIFIED DRUG; ZINC;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS; WILD TYPE; AMINO ACID SEQUENCE; BIOCATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; X RAY CRYSTALLOGRAPHY;

NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS SEROGROUP B;

AMINO ACID SEQUENCE; BACTERIAL OUTER MEMBRANE PROTEINS; BINDING SITES; BIOCATALYSIS; CRYSTALLOGRAPHY, X-RAY; METALLOPROTEASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP B; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN; ZINC;

EID: 80055059409     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026845     Document Type: Article

References (35)

1. Hart CA, Rogers TR, (1993) Meningococcal disease. J Med Microbiol 39: 3-25.
2. Stephens DS, Greenwood B, Brandtzaeg P, (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210.
3. Frosch M, Maiden MC, (2006) The population biology of Neisseria meningitidis: implications for meningococcal disease, epidemiology and control. In: Frosch M, Maiden MC, editors. Handbook of Meningococcal disease. Infection biology, vaccination, clinical management Weinheim Wiley-VCH Verlag pp. 17-35.
4. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM, (2001) Meningococcal disease. N Engl J Med 344: 1378-1388.
5. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287: 1816-1820.
6. de Filippis I, (2009) Quest for a broad-range vaccine against Neisseria meningitidis serogroup B: implications of genetic variations of the surface-exposed proteins. J Med Microbiol 58: 1127-1132.
7. Schindler CA, Schuhardt VT, (1964) Lysostaphin: A New Bacteriolytic Agent for the Staphylococcus. Proc Natl Acad Sci U S A 51: 414-421.
8. Bochtler M, Odintsov SG, Marcyjaniak M, Sabala I, (2004) Similar active sites in lysostaphins and D-Ala-D-Ala metallopeptidases. Protein Sci 13: 854-861.
9. Rawlings ND, Morton FR, Barrett AJ, (2006) MEROPS: the peptidase database. Nucleic Acids Res 34: D270-272.
10. Hooper NM, (1994) Families of zinc metalloproteases. FEBS Lett 354: 1-6.
11. Ramadurai L, Lockwood KJ, Nadakavukaren MJ, Jayaswal RK, (1999) Characterization of a chromosomally encoded glycylglycine endopeptidase of Staphylococcus aureus. Microbiology 145: 801-808.
12. Sugai M, Fujiwara T, Akiyama T, Ohara M, Komatsuzawa H, et al. (1997) Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1. J Bacteriol 179: 1193-1202.
13. Barrett AJ, Rawlings ND, Woessner JF, (1998) Handbook of proteolytic enzymes. San Diego: Academic Press. xxix: 1666.
14. Odintsov SG, Sabala I, Marcyjaniak M, Bochtler M, (2004) Latent LytM at 1.3A resolution. J Mol Biol 335: 775-785.
15. Spencer J, Murphy LM, Conners R, Sessions RB, Gamblin SJ, (2010) Crystal structure of the LasA virulence factor from Pseudomonas aeruginosa: substrate specificity and mechanism of M23 metallopeptidases. J Mol Biol 396: 908-923.
16. Ragumani S, Kumaran D, Burley SK, Swaminathan S, (2008) Crystal structure of a putative lysostaphin peptidase from Vibrio cholerae. Proteins 72: 1096-1103.
17. Gustin JK, Kessler E, Ohman DE, (1996) A substitution at His-120 in the LasA protease of Pseudomonas aeruginosa blocks enzymatic activity without affecting propeptide processing or extracellular secretion. J Bacteriol 178: 6608-6617.
18. Kessler E, Safrin M, Gustin JK, Ohman DE, (1998) Elastase and the LasA protease of Pseudomonas aeruginosa are secreted with their propeptides. J Biol Chem 273: 30225-30231.
19. Blackman SA, Smith TJ, Foster SJ, (1998) The role of autolysins during vegetative growth of Bacillus subtilis 168. Microbiology 144: 73-82.
20. Smith TJ, Blackman SA, Foster SJ, (2000) Autolysins of Bacillus subtilis: multiple enzymes with multiple functions. Microbiology 146: 249-262.
21. Schleifer KH, Kandler O, (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36: 407-477.
22. Peters JE, Galloway DR, (1990) Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity. J Bacteriol 172: 2236-2240.
23. Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, et al. (2009) The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PLoS One 4: e7023.
24. Schielke S, Frosch M, Kurzai O, (2010) Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae. Med Microbiol Immunol 199: 185-196.
25. Holm L, Sander C, (1995) Dali: a network tool for protein structure comparison. Trends Biochem Sci 20: 478-480.
26. Ramadurai L, Jayaswal RK, (1997) Molecular cloning, sequencing, and expression of lytM, a unique autolytic gene of Staphylococcus aureus. J Bacteriol 179: 3625-3631.
27. Park PW, Pier GB, Preston MJ, Goldberger O, Fitzgerald ML, et al. (2000) Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem 275: 3057-3064.
28. Park PW, Pier GB, Hinkes MT, Bernfield M, (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411: 98-102.
29. Firczuk M, Mucha A, Bochtler M, (2005) Crystal structures of active LytM. J Mol Biol 354: 578-590.
30. Otwinowski Z, Minor W, (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307-326.
31. Pape T, Schneider TR, (2004) HKL2MAP: a graphical user interface for macromolecular phasing with SHELX programs. J Appl Crystallogr 37: 843-844.
32. Zwart PH, Afonine PV, Grosse-Kunstleve RW, Hung LW, Ioerger TR, et al. (2008) Automated structure solution with the PHENIX suite. Methods Mol Biol 426: 419-435.
33. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
34. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905-921.
35. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26: 283-291.